Compare Stocks → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:NTGNYSEARCA:SDYCNSX:VP Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNTGTortoise Midstream Energy Fund$40.60+1.2%$38.34$31.25▼$40.67N/AN/A12,681 shs8,158 shsSDYSPDR S&P Dividend ETF$132.46+0.2%$128.81$109.87▼$132.46$20.96B0.68359,450 shs137,952 shsVPVodis Pharmaceuticals$0.00$0.16▼$0.62N/AN/A1,714 shs51,582 shs10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNTGTortoise Midstream Energy Fund0.00%+2.09%+9.01%+12.47%+24.31%SDYSPDR S&P Dividend ETF0.00%+0.81%+5.42%+6.62%+9.03%VPVodis Pharmaceuticals0.00%0.00%0.00%0.00%0.00%Bible Shocker: Have You Seen Elon Musk’s Miracle? (Ad)Breaking News: Elon Musk Invents New Type of A.I. (Shocking) Elon Musk is about to shock the world again with this new type of A.I.… Minting new millionaires in the process.Click here for the full story…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationNTGTortoise Midstream Energy FundN/AN/AN/AN/AN/AN/AN/AN/ASDYSPDR S&P Dividend ETFN/AN/AN/AN/AN/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNTGTortoise Midstream Energy FundN/AN/AN/AN/ASDYSPDR S&P Dividend ETF0.00N/A$139.255.13% UpsideVPVodis PharmaceuticalsN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNTGTortoise Midstream Energy Fund$9.46MN/AN/AN/AN/AN/ASDYSPDR S&P Dividend ETFN/AN/AN/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNTGTortoise Midstream Energy FundN/A-$0.03N/A∞N/AN/AN/AN/AN/ASDYSPDR S&P Dividend ETFN/AN/A19.72∞N/AN/AN/AN/AN/AVPVodis PharmaceuticalsN/AN/A0.00N/AN/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNTGTortoise Midstream Energy Fund$3.087.59%N/AN/A 1 YearsSDYSPDR S&P Dividend ETF$3.202.42%N/AN/AN/AVPVodis PharmaceuticalsN/AN/AN/AN/AN/ALatest VP, ASY, NTG, and SDY DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/8/2024NTGTortoise Midstream Energy Fundquarterly$0.777.7%5/23/20245/24/20245/31/2024(Data available from 1/1/2013 forward)OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNTGTortoise Midstream Energy FundN/ASDYSPDR S&P Dividend ETFN/AVPVodis PharmaceuticalsN/AInsider OwnershipCompanyInsider OwnershipNTGTortoise Midstream Energy FundN/ASDYSPDR S&P Dividend ETFN/AVPVodis PharmaceuticalsN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableNTGTortoise Midstream Energy FundN/AN/AN/ANot OptionableSDYSPDR S&P Dividend ETFN/A158.20 millionN/ANot OptionableVPVodis PharmaceuticalsN/AN/AN/ANot OptionableVP, ASY, NTG, and SDY HeadlinesRecent News About These CompaniesMay 7, 2024 | tmcnet.comScorpius Holdings Appoints New VP of Business Development Shari Udoff-McDonaldMay 6, 2024 | reuters.comVP Harris announces more than $100 mln to support auto workersMarch 27, 2024 | tmcnet.comCOVETRUS® TRANSFORMS PRESCRIPTION MANAGEMENT FOR VETERINARY PRACTICES WITH INTRODUCTION OF vRxPro™March 22, 2024 | msn.comStates' drug pricing boards off to a slow startMarch 20, 2024 | mmm-online.comGLP-1s set to take drug sales throne from PD-1 inhibitors in 2024February 25, 2024 | msn.comVerrica Pharmaceuticals Set to Discuss Q4 and Full-Year 2023 Financial Results in Upcoming Conference CallFebruary 7, 2024 | markets.businessinsider.comAbivax appoints Ana Sharma as Vice President, Global Head of QualityJanuary 24, 2024 | markets.businessinsider.comMedicines360 Appoints Lisa David as Chair of the Board of Directors, Strengthening its Commitment to Women’s HealthDecember 20, 2023 | govtech.comSenior Vice PresidentDecember 14, 2023 | msn.comDr Reddy's becomes sole Indian pharma player to make it to Dow Jones Sustainability World Index 2023December 7, 2023 | msn.comBiden warns Big Pharma: Make your drugs cheaper or the US government will override your patentsDecember 7, 2023 | abcnews.go.comThe White House is threatening the patents of high-priced drugs developed with taxpayer dollarsDecember 1, 2023 | msn.comAmneal Pharma in pact with Strides to launch generic VascepaNovember 6, 2023 | markets.businessinsider.comAnavex Life Sciences Appoints Senior VP of Regulatory AffairsOctober 14, 2023 | foxnews.comXpeng's vice president suspended amid corruption investigation in supply chain managementOctober 9, 2023 | marketwatch.comLexicon Pharmaceuticals Up 20% on Express Scripts Designation for Inpefa Heart DrugOctober 4, 2023 | markets.businessinsider.comStrengthening of vertical integration: Exyte completes acquisition of pure media specialist IntegaSeptember 19, 2023 | newsweek.comVice PresidentAugust 28, 2023 | usatoday.comRepublican voters want Donald Trump. And his vice president? How about more Trump?August 22, 2023 | news.yahoo.comTeva Pharmaceuticals to pay $225M fine to settle price-fixing chargesNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Stocks Leading the U.S. Agriculture ComebackApril 26, 2024 10:10 AMView 3 Stocks Leading the U.S. Agriculture ComebackHow to Use Put Debit Spreads to Profit From Falling Stocks April 26, 2024 9:30 AMView How to Use Put Debit Spreads to Profit From Falling Stocks Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 monthsApril 26, 2024 3:21 AMView Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 monthsSeagate Technology Warns Cloud Demand is Heating Up April 30, 2024 10:10 AMView Seagate Technology Warns Cloud Demand is Heating Up GameStop is Roaring Based on Speculation Not SubstanceMay 13, 2024 11:10 AMView GameStop is Roaring Based on Speculation Not SubstanceAll HeadlinesCompany DescriptionsTortoise Midstream Energy FundNYSE:NTGTortoise MLP Fund, Inc. is a close ended equity mutual fund launched and managed by Tortoise Capital Advisors L.L.C. It invests in public equity markets. The fund primarily invests in equity securities of MLPs and their affiliates, with an emphasis on natural gas infrastructure Master Limited Partnerships. It employs a fundamental analysis with a bottom up stock picking approach with focus on factors like quantitative, qualitative, and relative value factors to create its portfolio. Tortoise MLP Fund, Inc. was formed on July 27, 2010 is domiciled in United States.SPDR S&P Dividend ETFNYSEARCA:SDYThe SPDR S&P Dividend ETF seeks to closely match the returns and characteristics of the S&P High Yield Dividend Aristocrats Index (the Index). The Index is designed to measure the performance of the 60 highest dividend yielding S&P Composite 1500 Index constituents that have followed a managed-dividends policy of consistently increasing dividends every year for at least 25 consecutive years. The Fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds (including money market funds advised by the Adviser). SSgA Funds Management, Inc. is the investment adviser to the Fund.Vodis PharmaceuticalsCNSX:VPVodis Pharmaceuticals Inc. operates as an application stage company for producing medical marijuana. It operates in Canada and the United States. The company is based in Delta, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.